chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Diarrhoea, Gastrooesophageal reflux disease, SARS-CoV-2 test
Clinical narrative: Loose stool; Diarrhea; Terrible reflux; This is a spontaneous report from a contactable other healthcare professional. A 68-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: Er2613) via an unspecified route of administration in the right arm on 31Mar2021 at 10:15(at the age of 67-years-old) as a single dose for COVID-19 immunisation. Medical history included diabetes and allergic to sunflower seed and oil(food allergy). Concomitant medications included insulin(MANUFACTURER UNKNOWN),metformin(MANUFACTURER UNKNOWN) and lisinopril (LISIPRIL),all from unknown dates and for unknown indications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: En6205) via an unspecified route of administration in the right arm on 10Mar2021 at 10:30(at the age of 67-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in 2021, the patient experienced terrible reflux(gastroesophageal reflux), loose stool and then diarrhea. The patient reported that it would be day 4(at the time of the report) of the issues. The patient did not receive any treatment for the reported events. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. On 02Apr2021, the patient underwent PCR COVID-19 test(nasal swab) and the result was negative. The clinical outcome of the event terrible reflux, loose stool and diarrhea was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Headache, Myalgia
Clinical narrative: Headache; Muscle soreness; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 68-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the left arm on 01Apr2021 at 12:30 (at the age of 68-years-old), as a single dose for COVID-19 immunisation. Medical history included chronic back pain. Concomitant medications included vitamin D3 (MANUFACTURER UNKNOWN), oxycodone (MANUFACTURER UNKNOWN), paracetamol (ACETAMINOPHEN) and multivitamin (MANUFACTURER UNKNOWN), all taken for unknown indications from unknown dates. The patient had no allergies to medication, food and other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02Apr2021 at 08:00, the patient experienced headache, muscle soreness and fatigue. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. The clinical outcome of the events headache, muscle soreness and fatigue were resolving at the time of this report.   No follow-up attempts are possible. No further information is expected.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Menstruation irregular
Clinical narrative: Caused me to start my period 3 weeks early.; This is a spontaneous report from a contactable consumer, the patient. A 37-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 31Mar2021 at 12:00 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. Medical history included endometriosis. Concomitant medication included escitalopram oxalate (LEXAPRO) from an unspecified date for an unknown indication.The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: UNKNOWN) via an unspecified route of administration in the left arm on 10Mar2021 at 12:00 (at the age of 37-years-old) as a single dose for COVID-19 immunisation and sulfamethoxazole; trimethoprim (BACTRIM) and amoxicillin (MANUFACTURER UNKNOWN) on an unknown date for an unspecified indication and experienced drug allergy.  Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 02Apr2021 at 12:00 the patient experienced that the vaccine caused her to start her period 3 weeks early. Her cycles were always regular and 28 days. Just finished her period one week prior. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the event. The clinical outcome of the event irregular periods was recovering at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 43.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Hot flush, Malaise
Clinical narrative: Fever,; Chilis/shivering; tiredness; headache; feeling unwel; hot flashes; muscle pain; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ep7533) via an unspecified route of administration in the arm right on 31Mar2021 at 10:15 (at the age of 43-year-old) as a single dose for COVID-19 immunisation. Concomitant medications included vitamin c [abscorbic acid] (MANUFACTURER UNKNOWN) and vitamin b12 (MANUFACTURER UNKNOWN). Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 31Mar2021 at 12:00 the patient experienced fever, chills, shivering, tiredness, headache, feeling unwell, hot flashes and muscle pain for 5 days with those symptoms. On 04Apr2021, the patient underwent a COVID-19 rapid test (Nasal Swab) and the result was Pending. The patient did not receive any treatment for the reported event. The events did not result in doctor or other healthcare professional office/clinic visits, and the emergency room/department or urgent care. The clinical outcome of the events Fever, Chilis, shivering, tiredness, headache, feeling unwell, hot flashes and muscle pain was recovering at the time of the report.   No follow-up attempts are possible. No further information is expected.
Age: 43.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia, Pyrexia, SARS-CoV-2 test
Clinical narrative: Fever,; Chilis/shivering; tiredness; headache; feeling unwel; hot flashes; muscle pain; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ep7533) via an unspecified route of administration in the arm right on 31Mar2021 at 10:15 (at the age of 43-year-old) as a single dose for COVID-19 immunisation. Concomitant medications included vitamin c [abscorbic acid] (MANUFACTURER UNKNOWN) and vitamin b12 (MANUFACTURER UNKNOWN). Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 31Mar2021 at 12:00 the patient experienced fever, chills, shivering, tiredness, headache, feeling unwell, hot flashes and muscle pain for 5 days with those symptoms. On 04Apr2021, the patient underwent a COVID-19 rapid test (Nasal Swab) and the result was Pending. The patient did not receive any treatment for the reported event. The events did not result in doctor or other healthcare professional office/clinic visits, and the emergency room/department or urgent care. The clinical outcome of the events Fever, Chilis, shivering, tiredness, headache, feeling unwell, hot flashes and muscle pain was recovering at the time of the report.   No follow-up attempts are possible. No further information is expected.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Chills, Decreased appetite, Dizziness, Dysgeusia
Clinical narrative: upper lip felt numb; Upper lip felt tingling; bitter/metallic taste; Nausea; Loss of appetite; Tingling legs; Heart racing; Chest tightness; Light headedness and dizziness; chills and trembling (felt like low circulation); Overall exhaustion; This is a spontaneous report from a contactable consumer.   A 58-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8743), via an unspecified route of administration in the left arm on 03Apr2021 at 17:45 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8743) as a single dose for COVID-19 immunisation.  Medical history included iodine allergy and allergy to melons. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications included acetylsalicylic acid (ASPIRIN) and vitamins (MANUFACTURER UNKNOWN); both taken for unspecified indications from an unknown date and unknown if ongoing.  The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously took epinephrine (MANUFACTURER UNKNOWN) on unknown dates for an unknown indication and experienced drug allergy.  On 03Apr2021 at 17:55, the patient experienced tingling legs, heart racing, chest tightness, light headedness and dizziness, and chills and trembling (felt like low circulation). On 03Apr2021 at 18:05, the patient experienced upper lip felt numb, upper lip felt tingling, bitter/metallic taste, nausea, and loss of appetite. After this on 03Apr2021, the patient had overall exhaustion. The patient did not receive any treatment for the events. The clinical outcomes of tingling legs, heart racing, chest tightness, light headedness and dizziness, and chills and trembling (felt like low circulation), upper lip felt numb, upper lip felt tingling, bitter/metallic taste, nausea, and loss of appetite, and fatigue, was recovered on unknown dates in Apr2021.    No follow-up attempts are required. No further information is expected.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Hypoaesthesia oral, Nausea, Palpitations, Paraesthesia
Clinical narrative: upper lip felt numb; Upper lip felt tingling; bitter/metallic taste; Nausea; Loss of appetite; Tingling legs; Heart racing; Chest tightness; Light headedness and dizziness; chills and trembling (felt like low circulation); Overall exhaustion; This is a spontaneous report from a contactable consumer.   A 58-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8743), via an unspecified route of administration in the left arm on 03Apr2021 at 17:45 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8743) as a single dose for COVID-19 immunisation.  Medical history included iodine allergy and allergy to melons. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications included acetylsalicylic acid (ASPIRIN) and vitamins (MANUFACTURER UNKNOWN); both taken for unspecified indications from an unknown date and unknown if ongoing.  The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously took epinephrine (MANUFACTURER UNKNOWN) on unknown dates for an unknown indication and experienced drug allergy.  On 03Apr2021 at 17:55, the patient experienced tingling legs, heart racing, chest tightness, light headedness and dizziness, and chills and trembling (felt like low circulation). On 03Apr2021 at 18:05, the patient experienced upper lip felt numb, upper lip felt tingling, bitter/metallic taste, nausea, and loss of appetite. After this on 03Apr2021, the patient had overall exhaustion. The patient did not receive any treatment for the events. The clinical outcomes of tingling legs, heart racing, chest tightness, light headedness and dizziness, and chills and trembling (felt like low circulation), upper lip felt numb, upper lip felt tingling, bitter/metallic taste, nausea, and loss of appetite, and fatigue, was recovered on unknown dates in Apr2021.    No follow-up attempts are required. No further information is expected.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia oral
Clinical narrative: upper lip felt numb; Upper lip felt tingling; bitter/metallic taste; Nausea; Loss of appetite; Tingling legs; Heart racing; Chest tightness; Light headedness and dizziness; chills and trembling (felt like low circulation); Overall exhaustion; This is a spontaneous report from a contactable consumer.   A 58-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8743), via an unspecified route of administration in the left arm on 03Apr2021 at 17:45 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8743) as a single dose for COVID-19 immunisation.  Medical history included iodine allergy and allergy to melons. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications included acetylsalicylic acid (ASPIRIN) and vitamins (MANUFACTURER UNKNOWN); both taken for unspecified indications from an unknown date and unknown if ongoing.  The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously took epinephrine (MANUFACTURER UNKNOWN) on unknown dates for an unknown indication and experienced drug allergy.  On 03Apr2021 at 17:55, the patient experienced tingling legs, heart racing, chest tightness, light headedness and dizziness, and chills and trembling (felt like low circulation). On 03Apr2021 at 18:05, the patient experienced upper lip felt numb, upper lip felt tingling, bitter/metallic taste, nausea, and loss of appetite. After this on 03Apr2021, the patient had overall exhaustion. The patient did not receive any treatment for the events. The clinical outcomes of tingling legs, heart racing, chest tightness, light headedness and dizziness, and chills and trembling (felt like low circulation), upper lip felt numb, upper lip felt tingling, bitter/metallic taste, nausea, and loss of appetite, and fatigue, was recovered on unknown dates in Apr2021.    No follow-up attempts are required. No further information is expected.
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Pyrexia
Clinical narrative: Fever (102 F); This is a spontaneous report from a non-contactable consumer, the patient. A 37-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0151) via an unspecified route of administration in the right arm on 03Apr2021 at 15:15 (at the age of 37-years-old), as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6204) via an unspecified route of administration on 14Mar2021 at 13:15 (at the age of 37-years-old), as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 04Apr2021 at 04:00, the patient experienced fever (102 F). The events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. The patient did not receive any treatment for the event. The clinical outcome of the event fever (102 F) was resolved on 04Apr2021.   No follow-up attempts are possible. No further information is expected.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Vision blurred
Clinical narrative: hazy vision in both eyes; This is a spontaneous report from a non-contactable consumer, the patient. A 59-year-old female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 03Apr2021 at 10:00 (at the age of 59-years-old), as a single dose for COVID-19 immunisation. Medical history was reported as none. The patient did not take any concomitant medications. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, it was unknown if the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 04Apr2021 at 12:00 the patient experienced hazy vision in both eyes. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event hazy vision was not recovered at the time of report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Fatigue, Headache, Myalgia, Pyrexia
Clinical narrative: dizziness; vomiting; muscle aches/pains; headache; fatigue/tiredness; fever; This is a spontaneous report from a contactable consumer, the patient. A 38-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the left arm on 03Apr2021 at 10:00 (at the age of 38-years-old), as a single dose for COVID-19 immunisation. Medical history included diabetic, fibromyalgia and fatty liver. Concomitant medications included insulin detemir (LEVEMIR), metformin (MANUFACTURER UNKNOWN), atorvastatin (MANUFACTURER UNKNOWN), lisinopril (MANUFACTURER UNKNOWN) and trad (as reported); all for unspecified indication from an unknown date. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6207) via an unspecified route of administration in the left arm on 13Mar2021 at 09:45 (at the age of 38-years-old), as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient had no known allergies to medications, food or other products. On 03Apr2021 at 18:30 the patient experienced vomiting, muscle aches/pains, headache, dizziness, fatigue/tiredness and fever. It was unknown if the patient received any treatment for the reported events. The clinical outcome of the events vomiting, muscle aches, headache, dizziness, tiredness and fever were not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: dizziness; vomiting; muscle aches/pains; headache; fatigue/tiredness; fever; This is a spontaneous report from a contactable consumer, the patient. A 38-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the left arm on 03Apr2021 at 10:00 (at the age of 38-years-old), as a single dose for COVID-19 immunisation. Medical history included diabetic, fibromyalgia and fatty liver. Concomitant medications included insulin detemir (LEVEMIR), metformin (MANUFACTURER UNKNOWN), atorvastatin (MANUFACTURER UNKNOWN), lisinopril (MANUFACTURER UNKNOWN) and trad (as reported); all for unspecified indication from an unknown date. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6207) via an unspecified route of administration in the left arm on 13Mar2021 at 09:45 (at the age of 38-years-old), as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient had no known allergies to medications, food or other products. On 03Apr2021 at 18:30 the patient experienced vomiting, muscle aches/pains, headache, dizziness, fatigue/tiredness and fever. It was unknown if the patient received any treatment for the reported events. The clinical outcome of the events vomiting, muscle aches, headache, dizziness, tiredness and fever were not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 20.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Palpitations
Clinical narrative: Heart palpitations that persisted for over 5 days after the initial vaccine.; Minor shortness of breath.; This is a spontaneous report from a contactable consumer, the patient. A 20-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the arm left on 29Mar2021 at 17:00 (at the age of 20-year-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient did not have allergies to medications, food, or other products. Concomitant medications included cannabis sativa [marijuana] (MANUFACTURER UNKNOWN) started on an unspecified date for an unknown indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 29Mar2021 at 22:00, the patient experienced heart palpitations that persisted for over 5 days after the initial vaccine and minor shortness of breath. The event resulted in doctor or other healthcare professional office/clinic visit. The patient did not receive any treatment for the reported events. The clinical outcome of the events heart palpitations that persisted for over 5 days after the initial vaccine and minor shortness of breath was not recovered at the time of the report.  No follow-up attempts are needed. No further information is expected.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Acne cystic, Aphthous ulcer
Clinical narrative: A large canker sore developed under my tongue; A large acne cyst on my left buttock.; This is a spontaneous report from a contactable consumer, the patient. A 62-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737), via an unspecified route of administration in the arm right on 31Mar2021 at 15:15 (at the age of 62-year-old), as a single dose for COVID-19 immunisation. Medical history included functional heart murmur, bilirubin elevated and psoriasis. Concomitant medications included ECITALOP 10milligrams since an unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01Apr2021 at 17:00, the patient experienced a large canker sore developed under tongue and a large acne cyst on left buttock. The adverse events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events a large canker sore developed under tongue and large acne cyst on left buttock was recovering.  No follow-up attempts are needed. No further information is expected.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Headache, Pain, Pyrexia
Clinical narrative: Body aches; 99-101 degree fever; Chills; Headaches; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0151) via an unspecified route of administration in the right arm on 03Apr2021 at 11:30 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included venlafaxine hydrochloride (EFFEXOR), fexofenadine hydrochloride (ALLEGRA), calcium glycerophosphate (PRELIEF), and fluticasone propionate (FLUTICASONE PROPIONATE GLUCOCORTICOID) all from an unknown date for an unspecified indication. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6204) via an unspecified route of administration in the right arm on 14Mar2021 at 11:15 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 04Apr2021 at 00:30 the patient experienced fever 99-101 degree (UNITS UNSPECIFIED), headache, chills, general body pain. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Clinical outcome of events fever, chills, headache, general body pain was resolving at the time of reporting.   No follow-up attempts are needed. No further information is expected.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Nausea, Pyrexia
Clinical narrative: Nausea; Chills; Fever; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 34-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 31Mar2021 at 15:45 (at the age of 34-year-old) as a single dose for COVID-19 immunisation. Medical history included, asthma, hypertension and migraine. The patient had allergies to medications, food, or other products. The patient received unspecified medication within two weeks of vaccination. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 04Apr2021 at 08:30, the patient experienced nausea, chills, fever and fatigue. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events nausea, chills, fever and fatigue was recovering.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Feeling abnormal, Headache, Nausea
Clinical narrative: Nausea; Headache; extreme headache; Tiredness; Brain fog; This is a spontaneous report from a non-contactable consumer, the patient. A 53-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the left arm on 2Apr2021 at 13:15(at the age of 53-years-old) as a single dose for COVID-19 immunisation. Medical history included hypothyroidism. The patient did not have any allergies to medications, food, or other products. Concomitant medications included levothyroxine sodium (LEVOTHYROXINE), cetirizine hydrochloride (ZYRTEC), guaifenesin, pseudoephedrine hydrochloride (SUDAFED), multivitamin (UNKNOWN MANUFACTURER), Ademetionine 1,4-butanedisulfonate (SAMe); all from unknown dates for unknown indications. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 2Apr2021 at 20:30, the patient experienced, on the night of the injection, nausea, and on the following night headache, following morning extreme headache, tiredness and brain fog. The patient did not receive any treatment for the event.  The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events nausea, headache/extreme headache, tiredness and brain fog were recovering at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Anxiety, Headache, Neck pain, Tinnitus
Clinical narrative: Ringing in ears; Slight headache; Moderate neck ache; General feeling of unease/anxiety; This is a spontaneous report from a contactable consumer, the patient. A 54-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 15Mar2021 at 01:15(at the age of 54-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Patient did not receive any other medications within 2 weeks of vaccination. The patient previously received ciprofloxacin (MANUFACTURER UNKNOWN) and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 22Mar2021, the patient experienced ringing in ears, slight headache, moderate neck ache and general feeling of unease/anxiety. The events did not result in doctor or other healthcare professional office/clinic visit/ emergency visit. Patient did not receive any treatment for the adverse event. The clinical outcome of the events ringing in ears, slight headache, moderate neck ache and general feeling of unease/anxiety were not resolved at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Headache, Pain, Vomiting
Clinical narrative: Body aches; Diarrhea; Severe headache; Vomiting; This is a spontaneous report from a contactable healthcare professional, the patient. A 60-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 31Mar2021 (at the age of 60-year-old) as a single dose for COVID-19 immunisation. Medical history included blood pressure high. The patient did not had any allergies to medications, food, or other products. The patient received unspecified other medications within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN0202) via an unspecified route of administration in the left arm on 03Mar2021(at the age of 59-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 31Mar2021, the patient experienced severe headache, vomiting, diarrhoea and body aches for four days. The patient received treatment for the reported events. The events resulted in doctor or other healthcare professional office/clinic visit. The clinical outcome of the events of headache, general body pain, vomiting and diarrhoea was recovered on 04Apr2021.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Lymph node pain, Lymphadenopathy
Clinical narrative: Severe swollen glands. Started in lymph node near collarbone on the side where I got the injection.; Lymph nodes in neck were painful; This is a spontaneous report from a contactable consumer, the patient. A 54-year-old non-pregnant female patient received her second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration in the left arm on 30Mar2021 at 10:30 (at the age of 54-year-old) as a single dose for COVID-19 immunisation. Medical history included diabetes and asthma. The patient did not have any allergies to food, medications, or other products. Concomitant medications included metformin (MANUFACTURER UNKNOWN), dulaglutide (TRULICITY) and dapagliflozin propanediol monohydrate (FARXIGA) all from an unknown date for an unknown indication. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Eng204) via an unspecified route of administration in the right arm on 07Mar2021 at 15:30 (at the age of 54-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02Apr2021 at 16:00, 3 days after the vaccination, the patient experienced severe swollen glands started in the lymph node near the collarbone on the side where she got the injection and lymph nodes in the neck were painful in the next days. The events did not result in doctor or other healthcare professional office or clinic visit, and emergency room or department or urgent care. The clinical outcome of the event severe swollen glands started in the lymph node near the collarbone and lymph nodes in the neck painful were not recovered at the time of the report.   No follow-up attempts are needed. No further information is expected.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Tremor
Clinical narrative: Shaking of hands; This is a spontaneous report from a contactable consumer, the patient. A 30-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 22Mar2021 at 07:30 (at the age of 30-years-old) as a single dose for COVID-19 immunisation. Medical history included epilepsy. The patient had no known allergies. Concomitant medications included lamotrigine (LAMICTAL XR)  and zonisamide (MANUFACTURER UNKNOWN). Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 23Mar2021 at 04:00, the patient experienced shaking of hands. The adverse event resulted in a visit to the doctors or other healthcare professional office/clinic visit. It was unknown whether the patient had received any treatment for the reported event. The clinical outcome of the event shaking of hands was not recovered at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Decreased appetite, Fatigue, Headache, Pain
Clinical narrative: Whole body aches; chills; headache; extreme fatigue; lack of appetite; slight rash; feverish; This is a spontaneous report from a contactable consumer, the patient. A 74-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an unspecified route of administration in the left arm on 18Mar2021 at 18:00 (at the age of 74-years-old) as a single dose for COVID-19 immunisation. Medical history included osteoarthritis and sleep apnea. Concomitant medications included amlodipine (MANUFACTURER UNKNOWN), valsartan (MANUFACTURER UNKNOWN), timolol maleate, brimonidine tartrate (COMBIGAN) and LATANAP, all taken for unknown indication from an unspecified date. The patient previously received VICODIN on unknown date for pain and experienced drug allergy. The patient also had allergy to related pain killers. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6198) via an unspecified route of administration in the left arm on 26Feb2021 at 16:00 (at the age of 74-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 31Mar2021 at 03:30 the patient experienced whole body aches, chills, headache, fatigue extreme, lack of appetite, slight rash and feverish. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit and emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported events. The clinical outcomes of the events whole body aches, chills, headache, fatigue extreme, lack of appetite, slight rash and feverish were recovered on an unknown date in 2021.  No follow-up attempts are needed. No further information is expected.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Rash
Clinical narrative: Whole body aches; chills; headache; extreme fatigue; lack of appetite; slight rash; feverish; This is a spontaneous report from a contactable consumer, the patient. A 74-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an unspecified route of administration in the left arm on 18Mar2021 at 18:00 (at the age of 74-years-old) as a single dose for COVID-19 immunisation. Medical history included osteoarthritis and sleep apnea. Concomitant medications included amlodipine (MANUFACTURER UNKNOWN), valsartan (MANUFACTURER UNKNOWN), timolol maleate, brimonidine tartrate (COMBIGAN) and LATANAP, all taken for unknown indication from an unspecified date. The patient previously received VICODIN on unknown date for pain and experienced drug allergy. The patient also had allergy to related pain killers. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6198) via an unspecified route of administration in the left arm on 26Feb2021 at 16:00 (at the age of 74-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 31Mar2021 at 03:30 the patient experienced whole body aches, chills, headache, fatigue extreme, lack of appetite, slight rash and feverish. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit and emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported events. The clinical outcomes of the events whole body aches, chills, headache, fatigue extreme, lack of appetite, slight rash and feverish were recovered on an unknown date in 2021.  No follow-up attempts are needed. No further information is expected.
Age: 41.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Clumsiness, Dizziness, Eye swelling
Clinical narrative: A small triangular patch was still swollen under my left eye; a racing heart; severe headache.; Dizzy moments,; feelings of clumsiness; Chills; pain in right knee; pain in left shoulder; mouth and left side of  face felt numb; mouth and left side of  face started swelling; This is a spontaneous report from a contactable consumer, the patient. A 41-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE: Lot Number: ER8737) via an unspecified route of administration in the arm left on 03Apr2021 at 09:15 (at the age of 41-year-old) as a single dose for COVID-19 immunisation. Medical history included hypothyroidism and general allergies. Patient had birch allergy (as child) and had reactions (fever) after vaccines as a young child. The patient did not have any concomitant medications. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 03Apr2021 at 09:45, the patient experienced numbness, swelling face, dizziness, clumsiness, chills, pain in knee and pain in shoulder and at 3:00 he experienced severe headache. On 04Apr2021, the patient experienced a racing heart and  on 05Apr2021, the patient experienced eye swelling. 30 minutes after the vaccine, the patient noticed his mouth and left side of face felt numb and started to swell as he was driving. The sensation felt similar to dental work. It seemed to improve after 1-2 hours (went for a walk and started to do yard work). General numbness and swelling lasted all day. On day 2, a small triangular patch was still swollen under his left eye. In the night (of day1) he woke up at 3:00 with a racing heart and severe headache and had a restless night thereafter (which is highly uncommon). Heart beat went back to normal after waking up and walking outside. Other less severe and persistent symptoms included dizzy moments, feelings of clumsiness (fell playing sports with son, missed a stair), chills, pain in right knee, pain in left shoulder, The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event headache, dizziness, clumsiness, chills, pain in knee, pain in shoulder and eye swelling was recovering at the time of this report. The clinical outcome of the event numbness and swelling face was recovered on 03Apr2021 and racing heart recovered on 04Apr2021.    No follow-up attempts are needed. No further information is expected.
Age: 41.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Hypoaesthesia, Palpitations, Swelling face
Clinical narrative: A small triangular patch was still swollen under my left eye; a racing heart; severe headache.; Dizzy moments,; feelings of clumsiness; Chills; pain in right knee; pain in left shoulder; mouth and left side of  face felt numb; mouth and left side of  face started swelling; This is a spontaneous report from a contactable consumer, the patient. A 41-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE: Lot Number: ER8737) via an unspecified route of administration in the arm left on 03Apr2021 at 09:15 (at the age of 41-year-old) as a single dose for COVID-19 immunisation. Medical history included hypothyroidism and general allergies. Patient had birch allergy (as child) and had reactions (fever) after vaccines as a young child. The patient did not have any concomitant medications. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 03Apr2021 at 09:45, the patient experienced numbness, swelling face, dizziness, clumsiness, chills, pain in knee and pain in shoulder and at 3:00 he experienced severe headache. On 04Apr2021, the patient experienced a racing heart and  on 05Apr2021, the patient experienced eye swelling. 30 minutes after the vaccine, the patient noticed his mouth and left side of face felt numb and started to swell as he was driving. The sensation felt similar to dental work. It seemed to improve after 1-2 hours (went for a walk and started to do yard work). General numbness and swelling lasted all day. On day 2, a small triangular patch was still swollen under his left eye. In the night (of day1) he woke up at 3:00 with a racing heart and severe headache and had a restless night thereafter (which is highly uncommon). Heart beat went back to normal after waking up and walking outside. Other less severe and persistent symptoms included dizzy moments, feelings of clumsiness (fell playing sports with son, missed a stair), chills, pain in right knee, pain in left shoulder, The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event headache, dizziness, clumsiness, chills, pain in knee, pain in shoulder and eye swelling was recovering at the time of this report. The clinical outcome of the event numbness and swelling face was recovered on 03Apr2021 and racing heart recovered on 04Apr2021.    No follow-up attempts are needed. No further information is expected.
Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Headache, Pyrexia
Clinical narrative: Headache; fatigue; Mild fever; This is a spontaneous report from a contactable consumer, the patient. A 44-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 03Apr2021 at 09:45(at the age of 44-year-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. Concomitant medications included rosuvastatin (MANUFACTURER UNKNOWN) from unknown date for unknown indication. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 03Apr2021 at 21:00, the patient experienced headache, fatigue and mild fever. The patient received tylenol at home as treatment of the reported events. The adverse events did not result in a visit to the doctors or other healthcare professional office/clinic visit and emergency room/department or urgent care. The clinical outcome of the event headache, fatigue and mild fever was recovering at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.